Literature DB >> 9803965

Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients.

E van der Ryst1, M Kotze, G Joubert, M Steyn, H Pieters, M van der Westhuizen, M van Staden, C Venter.   

Abstract

Depletion of CD4+ T cells is one of the hallmarks of progression of HIV-1 infection. However, measurement of the CD4+ T-cell count is expensive and often unavailable in less developed areas. Previous studies have suggested that the total lymphocyte count (TLC) can be used to predict a low absolute CD4+ T-cell count. To determine the relationship between TLC and CD4+ T-cell count in HIV-1-infected South African patients, 2777 HIV-1-seropositive patients visiting the Immunology clinic at the Pelonomi Hospital in Bloemfontein, South Africa from April 1991 to April 1997 were included in the study. In total, 3237 observations were used to determine sensitivity, specificity, and likelihood ratios, with 95% confidence intervals, of various cutpoints of the TLC to predict an absolute CD4+ T-cell count of <200 cells/mm3, CD4+ percentage <20%, and CD4+ percentage <15%. Spearman rank correlations were calculated between TLC and CD4+ T cells, CD4+ percentage and CD8+ T cells, as well as between CD4+ and CD8+ T cells. Results demonstrated that a TLC of 2 x 10(9)/L or less had a sensitivity of 90.3% to detect patients with a CD4+ T-cell count of <200 cells/mm3, but a specificity of only 53.7%. When the TLC cutoff value was lowered, specificity increased but sensitivity decreased. For the observations as a group, a correlation (r = 0.704) between CD4+ T-cell count and TLC was demonstrated, but if the patients were divided into three groups according to their CD4+ T-cell count, this correlation weakened considerably. Therefore, although TLC shows a correlation with CD4+ T-cell count, it is not a good predictor of the CD4+ T-cell count in this population and should preferably not be used in the clinical care of HIV/AIDS patients.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Biology; Correlation Studies; Developing Countries; Diseases; English Speaking Africa; Hiv Infections; Immunity; Immunologic Factors; Measurement; Physiology; Research Methodology; Research Report; Signs And Symptoms; South Africa; Southern Africa; Statistical Studies; Studies; Viral Diseases

Mesh:

Year:  1998        PMID: 9803965     DOI: 10.1097/00042560-199811010-00005

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  9 in total

1.  Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.

Authors:  W K B A Owiredu; L Quaye; N Amidu; O Addai-Mensah
Journal:  Afr Health Sci       Date:  2011-03       Impact factor: 0.927

2.  Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.

Authors:  Philippa M Musoke; Alicia M Young; Maxensia A Owor; Irene R Lubega; Elizabeth R Brown; Francis A Mmiro; Lynne M Mofenson; J Brooks Jackson; Mary Glenn Fowler; Laura A Guay
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

3.  Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.

Authors:  Moses R Kamya; Fred C Semitala; Thomas C Quinn; Allan Ronald; Denise Njama-Meya; Harriet Mayanja-Kizza; Elly T Katabira; Lisa A Spacek
Journal:  Afr Health Sci       Date:  2004-08       Impact factor: 0.927

4.  Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India.

Authors:  S Srirangaraj; D Venkatesha
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

5.  Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings.

Authors:  Christian Obirikorang; Lawrence Quaye; Isaac Acheampong
Journal:  BMC Infect Dis       Date:  2012-06-07       Impact factor: 3.090

6.  Comparing absolute lymphocyte count to total lymphocyte count, as a CD4 T cell surrogate, to initiate antiretroviral therapy.

Authors:  Srirangaraj Sreenivasan; Venkatesha Dasegowda
Journal:  J Glob Infect Dis       Date:  2011-07

7.  Predictors of early death in a cohort of Ethiopian patients treated with HAART.

Authors:  Degu Jerene; Aschalew Endale; Yewubnesh Hailu; Bernt Lindtjørn
Journal:  BMC Infect Dis       Date:  2006-09-01       Impact factor: 3.090

8.  Absolute lymphocyte count is not a suitable alternative to CD4 count for determining initiation of antiretroviral therapy in fiji.

Authors:  Dashika A Balak; Karen Bissell; Christine Roseveare; Sharan Ram; Rachel R Devi; Stephen M Graham
Journal:  J Trop Med       Date:  2014-10-27

9.  Evaluation of Individual and Combined Markers of Urine Dipstick Parameters and Total Lymphocyte Count as a Substitute for CD4 Count in Low-Resource Communities in Ghana.

Authors:  Enoch Odame Anto; Christian Obirikorang; Emmanuel Acheampong; Bright Amankwaa; Bright Oppong Afranie; Sampson Donkor; Isaac Hope; Juliana Jommo; Esther Osaah
Journal:  Dis Markers       Date:  2018-02-11       Impact factor: 3.434

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.